罗亚
心力衰竭
细胞生物学
串扰
癌症研究
化学
信号转导
转录因子
生物
药理学
医学
细胞
肌肉肥大
心肌肥大
RAC1
小型GTPase
内生
细胞信号
GTP酶
内科学
基因表达调控
可药性
免疫组织化学
作者
Mengzhu Xue,Yingquan Liang,Zhen Yuan,Xiangning Liu,Longfeng Chang,Yongzhi Wang,Peijia Xu,Tingting Zhang,Hewei Jiang,Zijie Zhao,Jingqiu Liu,Shanshan Ruan,Tianyu Ye,Xuelian Pang,梅文一,Jiawen Wang,Xiaoqian Sun,Huijuan Wang,Jian Cui,Yao Zu
出处
期刊:Circulation Research
[Lippincott Williams & Wilkins]
日期:2026-03-20
卷期号:138 (10): e327107-e327107
被引量:5
标识
DOI:10.1161/circresaha.125.327107
摘要
BACKGROUND: Given the persistently high morbidity and mortality of heart failure (HF), targeting myocardial remodeling, particularly pathological hypertrophy and fibrosis, has become a major therapeutic priority. RhoA (Ras homolog gene family member A), a small GTPase governing cytoskeletal reorganization and cell migration, plays a pivotal role in this process. However, RhoA has long been considered undruggable because of its high-affinity binding to GDP/GTP and the absence of well-defined druggable pockets. METHODS: Structural analyses comparing RhoA-GTP and RhoA-GDP conformations, combined with surface plasmon resonance-based screening, were used to identify a RhoA inhibitor. The underlying mechanism was validated in cultured cells and 3-dimensional myocardial tissue models. Therapeutic efficacy was assessed across multiple species of HF models and supported by multiomics analyses linking RhoA activation to human HF. Key findings were further confirmed by multiplex immunohistochemistry and pulldown assays in human heart specimens. RESULTS: We identified an unrecognized cryptic pocket adjacent to GDP in RhoA. A natural product, AH001, selectively occupied this pocket and interacted with GDP, thereby stabilizing the interaction between RhoA and its endogenous inhibitor, RhoGDIα (Rho GDP-dissociation inhibitor 1). AH001 suppressed downstream signaling by reducing MRTFA (myocardin-related transcription factor A) nuclear translocation and downregulating fibrosis- and hypertrophy-related proteins. Moreover, AH001 disrupted pathological crosstalk between Mrtfa + cardiomyocytes and fibroblasts. Consequently, AH001 markedly attenuated myocardial remodeling in multiple HF animal models, as well as in 3-dimensional myocardial tissue models. CONCLUSIONS: These findings establish pharmacological inhibition of RhoA activation as a viable strategy to mitigate myocardial remodeling in HF and provide a conceptual framework for developing reversible inhibitors against previously undruggable small GTPases.
科研通智能强力驱动
Strongly Powered by AbleSci AI